Late-stage diagnosis of carcinoid heart disease due to lack of access to health care

Carcinoid syndrome (CS) is a unique constellation of symptoms caused by release of vasoactive substances from neuroendocrine tumors (Pandit et al., StatPearls, 2022). Neuroendocrine tumors are rare with an annual incidence of 2 in 100,000 people (Ram et al., 46:21-27, 2019). Up to 50% of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Aditi, Fierro, Maria E., Pak, Stella, Thallapureddy, Keerthi, Awobajo, Moyosore, Hui, Dawn, Otchere, Prince
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240769/
https://www.ncbi.nlm.nih.gov/pubmed/37277819
http://dx.doi.org/10.1186/s40959-023-00176-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240769/
https://www.ncbi.nlm.nih.gov/pubmed/37277819
http://dx.doi.org/10.1186/s40959-023-00176-z

Ejemplares similares